Cholangiocarcinoma: spectrum of appearances on Gd-EOB-DTPA-enhanced MR imaging and the effect of biliary function on signal intensity

scientific article

Cholangiocarcinoma: spectrum of appearances on Gd-EOB-DTPA-enhanced MR imaging and the effect of biliary function on signal intensity is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1001591850
P356DOI10.1186/S12885-015-1039-X
P932PMC publication ID4324426
P698PubMed publication ID25655565
P5875ResearchGate publication ID272079537

P2093author name stringHuasong Cai
Shi-Ting Feng
Yanji Luo
Zhi Dong
Zi-Ping Li
Ling Wu
Tao Chan
Keguo Zheng
P2860cites workMagnetic Resonance Imaging of cholangiocarcinomaQ34533339
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applicationsQ35676335
Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.Q37736159
Primovist, Eovist: what to expect?Q38002724
Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.Q38026533
Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and preventionQ40794590
Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumineQ43184817
Biliary MR imaging with Gd-EOB-DTPA and its clinical applicationsQ43230364
MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity.Q44871221
Intrahepatic cholangiocarcinoma: radiologic-pathologic correlationQ45001131
Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.Q46435374
Intraductal mucosal-spreading mucin-producing peripheral cholangiocarcinoma of the liverQ50189344
Hilar cholangiocarcinoma: MR correlation with surgical and histological findingsQ52847170
Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.Q53130915
Cyst-forming intraductal papillary neoplasm of the bile ducts: description of imaging and pathologic aspects.Q53195262
Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.Q53485824
Cholangiocarcinoma: spectrum of appearances on MR images using current techniques.Q53941633
Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluationQ72989307
MR imaging of intrahepatic cholangiocarcinoma with pathologic correlationQ73927764
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinomaQ74558715
Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinomaQ75233624
Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchymaQ80965276
Diagnostic challenge: intraductal neoplasms of the pancreatobiliary systemQ87431283
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectcholangiocarcinomaQ124292
P304page(s)38
P577publication date2015-02-06
P1433published inBMC CancerQ326300
P1476titleCholangiocarcinoma: spectrum of appearances on Gd-EOB-DTPA-enhanced MR imaging and the effect of biliary function on signal intensity
P478volume15

Reverse relations

Q33621543Multimodality imaging of intrahepatic cholangiocarcinomacites workP2860

Search more.